This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990 Apr 28;335(8696):1022-3.

doi: 10.1016/0140-6736(90)91076-m.

Ifosfamide in paediatric oncology: tried but not tested?

P J Shaw¹, T Eden

Affiliations

PMID: 1970073
DOI: 10.1016/0140-6736(90)91076-m

Review

Ifosfamide in paediatric oncology: tried but not tested?

P J Shaw et al. Lancet. 1990.

. 1990 Apr 28;335(8696):1022-3.

doi: 10.1016/0140-6736(90)91076-m.

Authors

P J Shaw¹, T Eden

Affiliation

¹ Department of Paediatric Haematology, Royal Hospital for Sick Children, Edinburgh, UK.

PMID: 1970073
DOI: 10.1016/0140-6736(90)91076-m

No abstract available

PubMed Disclaimer

Comment in

Ifosfamide for children with solid tumours.
[No authors listed] [No authors listed] Lancet. 1990 Jun 9;335(8702):1398-400. Lancet. 1990. PMID: 1971676 No abstract available.
Cyclophosphamide versus ifosfamide in paediatric oncology.
Kushner BH, Cheung NK. Kushner BH, et al. Lancet. 1990 Jul 28;336(8709):253-4. doi: 10.1016/0140-6736(90)91785-9. Lancet. 1990. PMID: 1973806 No abstract available.

Similar articles

Ifosfamide vs cyclophosphamide in cancer therapy.
Weiss RB. Weiss RB. Oncology (Williston Park). 1991 May;5(5):67-76; discussion 76-82, 84-6. Oncology (Williston Park). 1991. PMID: 1653004
Ifosfamide: an old drug recently rediscovered.
Cavalli F. Cavalli F. Eur J Cancer Clin Oncol. 1988 Jun;24(6):959-61. doi: 10.1016/0277-5379(88)90142-3. Eur J Cancer Clin Oncol. 1988. PMID: 3409945 No abstract available.
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
Bramwell VH, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verweij J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, et al. Bramwell VH, et al. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4. Cancer Chemother Pharmacol. 1993. PMID: 8453694 Clinical Trial.
Ifosfamide--pharmacology, safety and therapeutic potential.
Brade WP, Herdrich K, Varini M. Brade WP, et al. Cancer Treat Rev. 1985 Mar;12(1):1-47. doi: 10.1016/0305-7372(85)90011-8. Cancer Treat Rev. 1985. PMID: 3896483 Review. No abstract available.
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G, Steward WP, Verweij J, Mouridsen H, Bramwell V, Schütte J, van Oosterom A, Dombernowsky P, Buesa J, Van Glabekke M, et al. Blackledge G, et al. Semin Oncol. 1992 Feb;19(1 Suppl 1):14-8. Semin Oncol. 1992. PMID: 1411615 Review.

See all similar articles

Cited by

Progressive renal toxicity due to ifosfamide.
Heney D, Wheeldon J, Rushworth P, Chapman C, Lewis IJ, Bailey CC. Heney D, et al. Arch Dis Child. 1991 Aug;66(8):966-70. doi: 10.1136/adc.66.8.966. Arch Dis Child. 1991. PMID: 1718222 Free PMC article.
Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.
Skinner R, Cotterill SJ, Stevens MC. Skinner R, et al. Br J Cancer. 2000 May;82(10):1636-45. doi: 10.1054/bjoc.2000.1214. Br J Cancer. 2000. PMID: 10817497 Free PMC article.
High technology drugs for cancer: the decision process for adding to a formulary.
Glennie JL, Woloschuk DM, Hall KW. Glennie JL, et al. Pharmacoeconomics. 1993 Dec;4(6):405-13. doi: 10.2165/00019053-199304060-00003. Pharmacoeconomics. 1993. PMID: 10146908 No abstract available.
Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
Mulder RL, Paulides M, Langer T, Kremer LC, van Dalen EC. Mulder RL, et al. Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD006300. doi: 10.1002/14651858.CD006300.pub4. Cochrane Database Syst Rev. 2015. PMID: 26421585 Free PMC article.
Ifosfamide nephrotoxicity in paediatric cancer patients.
Ashraf MS, Brady J, Breatnach F, Deasy PF, O'Meara A. Ashraf MS, et al. Eur J Pediatr. 1994 Feb;153(2):90-4. doi: 10.1007/BF01959214. Eur J Pediatr. 1994. PMID: 8157032

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science